EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 2
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Regional News

DNA vaccine spurs antibodies against a common Parkinson’s target in mice

The neuronal protein alpha-synuclein has long been a target for Parkinson's disease research, but it has delivered mixed results across multiple different therapeutic...
18 January 2022 Regional News DNA | mice
Continue Reading →
Regional News

Verana Health lands J&J, Novo backing in $150M round to fund real-world database for drug, device development

With a new CEO at the helm, the recent launch of an artificial-intelligence-powered data analytics engine and, now, the close of its largest funding round to date, Ve...
18 January 2022 Regional News AI | Artificial Intelligence
Continue Reading →
Regional News

US faces ‘critical moment’ in pricing reform that ‘won’t come again,’ nonprofit founder says after tallying 554 new hikes

With 2021 over, the pharmaceutical industry kicked off the New Year with one of its favorite pastimes: raising the prices on hundreds of branded meds. Public and poli...
18 January 2022 Regional News COVID-19 | drugmakers
Continue Reading →
Regional News

With Voxzogo approvals adding up, BioMarin is underway with its ‘biggest launch,’ CEO says

BioMarin has plenty of experience launching rare disease drugs, but the company's newest rollout will feature some notable differences from its prior marketing effort...
18 January 2022 Regional News achondroplasia | BioMarin
Continue Reading →
Regional News

Emergent BioSolutions founder El-Hibri bids adieu after CDMO’s turbulent 2021

The man behind one of the top manufacturers for the U.S. Strategic National Stockpile is parting ways with the company after more than 20 years. Fuad El-Hibri, found...
18 January 2022 Regional News COVID-19 pandemic | El-Hibri
Continue Reading →
Regional News

Pfizer’s Cibinqo snags FDA approval to challenge Sanofi and Regeneron’s Dupixent in eczema

Look out, Sanofi and Regeneron: Pfizer is on the scene in atopic dermatitis with another blockbuster-to-be. Friday, the FDA approved the New York drugmaker's oral da...
18 January 2022 Regional News eczema | patients
Continue Reading →
Regional News

Daiichi Sankyo, with tighter focus on oncology, sells 8 aging US cardiovascular drugs to diversifying Cosette

With the acquisition of the U.S. sales and distribution rights of eight cardiovascular drugs from Daiichi Sankyo, Cosette Pharma of New Jersey is making a move toward...
18 January 2022 Regional News cardiovascular | drugs
Continue Reading →
Regional News

JPM 2022: Pfizer bumps Paxlovid production estimate to 120M for this year while also looking to add more capacity

Developing a COVID-19 vaccine at breakneck speed was a monumental achievement for Pfizer and BioNTech. The accompanying manufacturing effort is just as onerous. Simi...
11 January 2022 Regional News COVID-19 | manufacturing
Continue Reading →
Regional News

Merck, putting $150M on the table, doubles down on pledge to tackle maternal mortality and health inequities

Around the world, a woman dies every two minutes from pregnancy or childbirth complications, most of them preventable. Merck has spent the last decade trying to chang...
11 January 2022 Regional News childbirth | complications
Continue Reading →
Regional News

Catalent’s FDA write-up spurred Novo Nordisk’s Wegovy supply woes

Catalent received an FDA write-up for its syringe filling facility in Belgium, BioProcess International reports, adding that it is "allegedly" the culprit behind supp...
11 January 2022 Regional News Catalent | manufacturing
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2025, All Rights Reserved – Powered by Teksyte